Literature DB >> 15747353

Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.

Katharina Diepold1, Barbara Schütz, Kevin Rostasy, Bernd Wilken, Pia Hougaard, Flemming Güttler, Anne Romstad, Lisbeth Birk Møller.   

Abstract

Autosomal recessive forms of infantile dystonia due to mutations in the tyrosine hydroxylase (TH) gene have been described recently. The main clinical manifestations are Segawa's disease, or infantile hypokinetic rigid Parkinsonism. Here, we report on a patient with hyperrigidity, psychomotor developmental delay, and dystonic posturing of the hands, symptoms that appeared after a viral infection at the age of 14 months. Low homovanillic acid/5-hydroxyindolacetic acid (HVA/5HIAA) ratio in cerebrospinal fluid suggested a TH deficiency. Molecular analysis revealed a novel (H246Y) and a known (D498G) compound heterozygote mutation in the TH gene. The patient showed a remarkable response to treatment with levodopa. The new mutation and the association of viral infections with the onset and worsening of symptoms are discussed. (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15747353     DOI: 10.1002/mds.20416

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 2.  The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism.

Authors:  R Pons
Journal:  J Inherit Metab Dis       Date:  2008-12-26       Impact factor: 4.982

Review 3.  Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.

Authors:  Guney Bademci; Jeffery M Vance; Liyong Wang
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

4.  Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.

Authors:  Maria Stamelou; Niccolo E Mencacci; Carla Cordivari; Amit Batla; Nick W Wood; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

5.  An unusual presentation of tyrosine hydroxylase deficiency.

Authors:  Linn E Katus; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2017-12-05

6.  Intermittent neurologic decompensation: An underrecognized presentation of tyrosine hydroxylase deficiency.

Authors:  Marjolaine Champagne; Gabriella A Horvath; Sébastien Perreault; Julie Gauthier; Keith Hyland; Jean-François Soucy; Grant A Mitchell
Journal:  JIMD Rep       Date:  2022-06-06

Review 7.  Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.

Authors:  Han-Yu Dong; Jun-Yan Feng; Xiao-Jing Yue; Ling Shan; Fei-Yong Jia
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.